849

We investigate the effect of histone deacetylase (HDAC) inhibitors for the INK4 family genes. In this meeting of last year, we demonstrated that HDAC inhibitors, including Trichostatin A (TSA) and sodium butyrate, activate p19INK4d through the Sp1 binding site on the p19INK4d gene promoter in the human T cell leukemia cell line Jurkat. However, Jurkat cells delete p16INK4a and p15INK4b genes. Therefore, using human immortalized keratinocyte HaCaT cells normally conserve p15INK4b gene, we examine the effect of HDAC inhibitors for p15INK4b gene. HDAC inhibitors arrest the cell cycle of HaCaT cells at the G1 phase and inhibit cell growth. HDAC inhibitors stimulate the p15INK4b promoter activity and up-regulate the p15INK4b mRNA and protein levels, and then a hyperphosphorylated form of the RB protein is converted into a hypophosphorylated form in HaCaT cells. In addition, the overexpression of p15INK4b completely suppressed the colony formation of HaCaT cells. Our results suggest that p15INK4b is one of the important molecular targets of HDAC inhibitors. As a member of the INK4 family, the functional similarity to p16INK4a suggests that p15INK4b may function as a replacement for p16INK4a in case p16INK4a is inactivated. Therefore, transcriptionally regulated agents of the p15INK4b gene may contribute to new strategies for the prevention or therapy of malignancies, which we have termed ‘gene-regulating chemoprevention or chemotherapy’.

[Proc Amer Assoc Cancer Res, Volume 45, 2004]